RecruitingNCT06270602

The ONCOCAMP Study

A Retrospective-prospective, Observational, Multicentric Study to Record Data From the ROC Platform and Monitor the ROC Performance


Sponsor

National Cancer Institute, Naples

Enrollment

15,000 participants

Start Date

Jul 14, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

The present study is a retrospective-prospective observational and multicentric study aiming to collect data relating to all patients included in the ROC platform. All ROC centers will be involved in the present study.


Eligibility

Min Age: 18 Years

Inclusion Criteria2

  • signed informed consent
  • registration in the ROC platform

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERData collection (retrospective)

Collection of patient data entered in the ROC platform from the beginning activation of the platform (November 2018) until the date on which the study is approved by the local ethics committee

OTHERData collection (prospective)

Collection of patient data entered in the ROC platform from the date in which the study is approved by the local ethical committee


Locations(17)

A.O. Moscati

Avellino, Avellino, Italy

Asl Avellino

Avellino, Avellino, Italy

A.O. Rummo

Benevento, Benevento, Italy

Asl Benevento

Benevento, Benevento, Italy

Asl Caserta

Caserta, Caserta, Italy

A.O. S.Anna S. Sebastiano

Caserta, Caserta, Italy

Asl Napoli 2 Nord

Casavatore, Napoli, Italy

Asl Napoli 3 Sud

Ercolano, Napoli, Italy

A.O. Cardarelli

Naples, Napoli, Italy

A.O. Dei Colli

Naples, Napoli, Italy

Federico II

Naples, Napoli, Italy

I.N.T. Pascale

Naples, Napoli, Italy

A.O.U. Luigi Vanvitelli

Naples, Napoli, Italy

Asl Napoli 1 Centro

Naples, Napoli, Italy

Ospedale del Mare

Naples, Napoli, Italy

Asl Salerno

Salerno, Salerno, Italy

A.O.U. Ruggi

Salerno, Salerno, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06270602


Related Trials